Credit Agricole S A Moderna, Inc. Put Options Transaction History

Credit Agricole S A

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 14, 2024	SELL	$85.37 - $115.44 $25.6 Million - $34.6 Million	-300,000 Reduced 50.0%	300,000 $32 Million
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $3.48 Million - $5.22 Million	50,000 Added 9.09%	600,000 $59.7 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $28 Million - $36.7 Million	290,000 Added 111.54%	550,000 $56.8 Million
Q2 2023 Jul 31, 2023	BUY	$118.5 - $160.53 $14.8 Million - $20.1 Million	125,000 Added 92.59%	260,000 $31.6 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $678,300 - $985,100	-5,000 Reduced 3.57%	135,000 $20.7 Million

Q4 2022 Feb 13, 2023	SELL	$118.38 - $210.04 $1.68 Million - $2.98 Million	-14,200 Reduced 9.21%	140,000 $25.1 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $2.95 Million - $4.85 Million	-25,000 Reduced 13.95%	154,200 $18.2 Million
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $445,094 - $671,042	3,800 Added 2.17%	179,200 $25.6 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $17.2 Million - $32.1 Million	136,400 Added 349.74%	175,400 $30.2 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $8.81 Million - $14.4 Million	39,000 New	39,000 $9.91 Million

1,037

245M

12.1M

9.36M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $45.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

Stay updated on Credit Agricole S A with notifications on news.